Human papillomaviruses and cervical lesions in the Italian population

Women's Oncology Review

Volumn 4, Issue 2, 2004, Pages 79-84

  Buonaguro, F M ^a   Tornesello, M L ^a   Duraturo, M L ^a   Buonaguro, L ^a   Greggi, S ^b   Stellato, G ^b   Losito, S ^b   Botti, G ^b   Montella, M ^c   Sansone, M ^d   Piccoli, R ^d   Pilotti, S ^e   Stefanon, B ^e   De Palo, G ^e  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Medicina Interna   (Italy)

^c Department of Epidemiology   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E6; PROTEIN E7; PROTEIN P107; PROTEIN P110; PROTEIN P130; PROTEIN P53; RETINOBLASTOMA PROTEIN;

CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INVASIVE CARCINOMA; MOLECULAR PHYLOGENY; POLYMERASE CHAIN REACTION; REVIEW; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS MUTATION; VIRUS TYPING; WART VIRUS;

EID: 3342948499     PISSN: 14733404     EISSN: None     Source Type: Journal    
DOI: 10.1080/14733400410001721237     Document Type: Review

References (29)

1. zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 1989;49:4677-881
2. Schwarz E, Freese K, Gissmann L, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314:111-4
3. de Villiers EM. Human pathogenic papillomavirus types: an update. Curr Top Microbiol Immunol 1994;186:1-12
4. Riou G, Favre M, Jeannel D, et al. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 1990;335:1171-4
5. van den Brule AJ, Walboomers JMM, du Maine M, et al. Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 1991;48:404-8
6. Lorincz AT, Reid R, Jenson AB, et al. Human papillomavirus infection of the cervix: relative risk association of 15 common anogenital types. Obstet Gynecol 1992;79:328-37
7. McCance DJ, Kalache A, Ashdown KX, et al. Human papillomavirus type 16 and 18 in carcinomas of the penis from Brazil. Int J Cancer 1986;37:55-9
8. Tornesello ML, Buonaguro FM, Beth-Giraldo E, et al. Human papillomavirus (HPV) DNA in penile carcinomas and in two cell lines from high-incidence areas for genital cancers in Africa. Int J Cancer 1992;51:587-92
9. Parkin DM, Whelan SL, Ferlay J, eds, et al. Cancer Incidence in Five Continents. Lyonn: IARC Scientific Publications, 1997
10. Chan S-Y, Ho L, Ong C-K, et al. Molecular variants of human papillomavirus type 16 from four continents Suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol 1992;66:2057-66
11. Myers G, Baker C, Munger K, eds, et al. Human Papillomaviruses 1997. Los Alamos, New Mexico: Los Alamos National Laboratory, 1997
12. Dyson N, Howley PM, Munger K, et al. The human papillomavirus-16 E7 oncoprotein is able to bind the retinoblastoma gene product. Science 1989;243:934-7
13. Werness BAX, Levine AJ, Howley PM. Association of human papillomavirus type 16 and 18 E6 proteins with p53. Science 1990;248:76-9
14. Scheffner M, Huibregtse JM, Vierstra RD, et al. The HPV-16E6 and E6AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993;75:495-505
15. Scheffner M, Nuber U, Huibregtse JM. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 1995;373(6509):81-3
16. Crook T, Tidy JA, Vousden KH. Degradetion of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 1991;67:547-56
17. Sang B-C, Barbosa MS. Single amino acid substitutions in 'low risk' human papillomavirus (HPV) type 6 E7 protein enhances features characteristic of the 'high-risk' HPV E7 oncoproteins. Proc Natl Acad Sci USA 1992;89:8063-7
18. Fuchs PG, Pfister H. Transcription of papillomavirus genomes. Intervirology 1994;37:159-67
19. Buonaguro FM, Tornesello ML, Salatiello I, et al. The Uganda study on HPV variants and genital cancers. J Clin Virol 2000;19:31-41
20. Tornesello ML, Duraturo ML, Buonaguro L, et al. Human papillomavirus (HPV) type distribution in HIV-seropositive and -seronegative Italian women. In Monsonego J, ed. 5th International Multidisciplinary Congress - EUROGIN 2003. Bologna: Monduzzi, 2003:150-9
21. Tornesello ML, Buonaguro FM, Buonaguro L, et al. Sequence variations and viral genomic state of human papillomavirus type 16 in penile carcinomas from Ugandan patients [Abstract]. 16th International Papillomavirus Conference, Siena, Italy, 5-12 September 1997;161-2
22. Zehbe I, Wilander E, Delius H, et al. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 1998;58(4):829-33
23. Song YS, Kee SH, Kim JW, et al. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol Oncol 1997;66:275-81
24. Xi LF, Koutsky LA, Galloway DA, et al. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 1997;89:796-802
25. Xi LF, Critchlow CW, Wheeler CM, et al. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res 1998;58:3839-44
26. Berumen J, Ordonez RM, Lazcano E, et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 2001;93:1325-30
27. Stoppler MC, Ching K, Stoppler H, et al. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 1996;70:6987-93
28. Kammer C, Warthorst U, Torrez-Martinez N, et al. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol 2000;81 Pt 8:1975-81
29. Tornesello ML, Buonaguro FM, Buonaguro L, et al. Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas. J Gen Virol 2000;81:2969-82